Halberd Co. (OTCMKTS:HALB – Get Free Report) was the target of a significant growth in short interest in October. As of October 15th, there was short interest totaling 157,854 shares. Based on an average daily trading volume, of 1,826,875 shares, the days-to-cover ratio is presently 0.1 days.
Halberd Price Performance
Shares of OTCMKTS:HALB opened at $0.00 on Monday. Halberd has a 12-month low of $0.00 and a 12-month high of $0.00.
Halberd Company Profile
Halberd Corporation is a biotechnology and medical-device company focused on developing technologies intended to remove harmful substances from the bloodstream and potentially improve the treatment of neurological and other serious medical conditions.
The company has described its research around extracorporeal blood-cleansing systems, which are designed to process blood outside the body and target substances such as inflammatory cytokines and other potentially damaging molecules. Halberd has indicated that its technology may have applications in conditions including traumatic brain injury, post-traumatic stress disorder and neurodegenerative diseases.
Halberd Corporation is headquartered in the United States and trades on the over-the-counter market under the symbol HALB.
Recommended Stories
- Five stocks we like better than Halberd
- Uranium Prices Are Near Historic Highs—So Why Hasn’t Cameco Followed?
- Royal Caribbean Buys the Beach as Norwegian Fixes the Ship
- SK hynix Says Memory Demand Beats Supply Through 2030—What It Means for Micron and SanDisk
- STMicroelectronics Could Reach New Highs—Here’s What Needs to Happen
Receive News & Ratings for Halberd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halberd and related companies with MarketBeat.com's FREE daily email newsletter.
